Table 5.
Group | Target | ||||
---|---|---|---|---|---|
Tb.N (n) |
Tb.Th (µm) |
Tb.Sp (µm) |
TV/BV (%) |
Cb.Th (µm) |
|
SHAM | 3.60 ± 0.70*** | 8.25 ± 0.16** | 9.50 ± 1.03*** | 36.64 ± 3.27*** | 12.21 ± 0.14** |
OVX | 0.90 ± 0.32 | 7.96 ± 0.20 | 16.44 ± 1.51 | 20.31 ± 4.17 | 11.95 ± 0.11 |
OVX + N | 1.70 ± 0.67* | 8.12 ± 0.12 | 12.95 ± 1.92** | 25.36 ± 4.58* | 12.15 ± 0.21* |
OVX + H | 1.70 ± 0.48** | 8.13 ± 0.13* | 12.68 ± 0.65*** | 27.28 ± 1.94** | 12.12 ± 0.19** |
OVX + M | 1.60 ± 0.52* | 8.11 ± 0.17 | 13.09 ± 1.16*** | 26.58 ± 2.24** | 12.11 ± 0.24 |
OVX + L | 1.60 ± 0.52** | 8.17 ± 0.17 | 13.27 ± 0.87*** | 26.36 ± 2.26** | 12.14 ± 0.24 |
Note: *P < 0.05, **P < 0.01, and ***P < 0.001 compared with OVX group.